Clinical Trial Update: Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating transarterial chemoembolization with doxorubicin with or without everolimus for hepatocellular carcinoma has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Everolimus (everolimus)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: TERMINATED